Genital warts. Anogenital (venereal) warts
Conditions
Interventions
Intervention 1: Intervention group: Capsules containing 200 micrograms of selenium were prepared by Pourateb Pharmaceutical Company and one capsule was taken daily for eight weeks. Intervention 2: Con
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 49 Years
Inclusion criteria
Inclusion criteria: Women of childbearing age (15-49 years) Women who are sexually active No serious medical, renal or nutritional problems that may affect selenium levels in the body
Exclusion criteria
Exclusion criteria: Pregnant and lactating women Travel or change of residence and lack of patient control Use of medications or supplements containing trace elements such as selenium in the past three months Chemotherapy or radiotherapy Need to use invasive methods such as cryotherapy and cauterization Allergy to selenium as stated by the individual
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the number of genital wart lesions. Timepoint: 28 and 56 days after intervention. Method of measurement: The number of lesions will be assessed by direct observation by the researcher. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparing the size of genital wart lesions. Timepoint: 28 and 56 days after intervention. Method of measurement: The size of the lesions will be estimated by multiplying the two perpendicular major diameters of each lesion in million meters. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Balagar
Tabriz University of Medical Sciences
Outcome results
None listed